Skip Navigation

Examining Trump's Drug Pricing Plan (Guest: Henry Miller)

May 23, 2018

Heartland Research Fellow Sarah Lee gets the ins and outs of President Trump’s new drug pricing plan. Will it lower the cost of prescription drugs?

President Donald Trump unveiled a new drug-pricing plan in May 2018. The plan seeks to lower the cost of prescription drugs by implementing free-market solutions to the U.S. drug-pricing regime. Further, Trump’s plan aims to curb the influence of unfair negotiating practices overseas.

Henry I. Miller, MS, MD of the Hoover Institution spent many years at the FDA. He joins Sarah to speak about the new drug-pricing plan, where it meets the mark, and how it can be improved.

Sarah Lee is the managing editor of Health Care News and a research fellow at The Heartland Institute. @HCPolicy
Henry I. Miller, MS, MD, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution.